MBL International
MBL International Corporation (MBLI) is a leading life science company focused on providing solutions for researchers in the life sciences, drug discovery and development fields. Our special emphasis is on immunology, immuno-oncology, oncology and autoimmune disease areas. As a JSR Life Sciences Company, MBLI is committed to improve the probability of success, decrease timelines, and increase the efficacy of biologics-based therapies for the benefit of patients.
-
SEP 25, 2024Immunology
Published by Pirouz Daftarian, Ph.D. Enhanced Signal-to-Noise Ratio as a Primary Advantage of MBLI Tetramers Concerning ... -
JUL 30, 2024Immunology
Published by Beata Boczkowska, Ph.D. IL-18 is a potent pro-inflammatory cytokine that plays a vital role in the bod ...
-
MAY 06, 2024Immunology
Published by Bindi M. Doshi, PhD In the realm of immunodiagnostics, antibodies have long been invaluable tools, e ...
-
FEB 27, 2024Drug Discovery & Development
Published by Beata Boczkowska, Ph.D. The potential for personalized cancer treatment is fueling the need to i ...
-
NOV 07, 2023Immunology
Published by Beata Boczkowska, Ph.D. Interleukin-18 (IL-18) is an effective pro-inflammatory cytokine for the host defen ...
-
SEP 26, 2023Immunology
Published by Beata Boczkowska, Ph.D. Understanding how major histocompatibility complex class (MHC) molecules ...
-
MAY 02, 2023Immunology
Published by Bindi M. Doshi, PhD MHC-peptide exchange is considered to be tricky by researchers. ...
-
APR 24, 2023Cell & Molecular Biology
Published by Bindi M. Doshi, PhD on Mar 17, 2023 Organoids are 3D structures made up of cells that replic ...
-
MAR 27, 2023Cancer
Innate Immunity is a nonspecific host defense mechanism against foreign antigens. It is the first line of defense in a h ...
-
SEP 28, 2022Drug Discovery & Development
The significance of antibody based in vivo studies For both research and therapeutic purposes, antibodies ca ...
